2024-08-06 |
2024-08-06 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
3,407
-21.2%
1.89
USD 6,426
|
3,407
-21.2%
|
1.89
|
USD 6,426
|
|
2024-04-03 |
2024-04-03 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
2,214
-11.4%
2.78
USD 6,144
|
2,214
-11.4%
|
2.78
|
USD 6,144
|
|
2024-02-07 |
2024-02-06 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
438
-2.3%
3.03
USD 1,328
|
438
-2.3%
|
3.03
|
USD 1,328
|
|
2023-08-03 |
2023-08-02 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
3,407
-15.4%
3.21
USD 10,919
|
3,407
-15.4%
|
3.21
|
USD 10,919
|
|
2023-04-04 |
2023-04-04 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
2,214
-8.7%
3.27
USD 7,240
|
2,214
-8.7%
|
3.27
|
USD 7,240
|
|
2023-02-03 |
2023-02-02 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
439
-1.6%
3.53
USD 1,550
|
439
-1.6%
|
3.53
|
USD 1,550
|
|
2022-11-18 |
2022-11-16 |
B
Purchase
|
McCracken Joseph S
Non-Executive Director
|
4,000
+34.1%
5.03
USD 20,120
|
4,000
+34.1%
|
5.03
|
USD 20,120
|
|
2022-09-23 |
2022-09-23 |
B
Purchase
|
Hawkins Richard J
Chief Executive Officer
Executive Director
|
208
+4.9%
8.80
USD 1,830
|
208
+4.9%
|
8.80
|
USD 1,830
|
|
2022-09-23 |
2022-09-21 |
B
Purchase
|
Hawkins Richard J
Chief Executive Officer
Executive Director
|
2,214
+108.2%
8.84
USD 19,572
|
2,214
+108.2%
|
8.84
|
USD 19,572
|
|
2022-09-21 |
2022-09-20 |
B
Purchase
|
Hawkins Richard J
Chief Executive Officer
Executive Director
|
1,506
+278.4%
8.75
USD 13,178
|
1,506
+278.4%
|
8.75
|
USD 13,178
|
|
2022-09-21 |
2022-09-19 |
B
Purchase
|
Hawkins Richard J
Chief Executive Officer
Executive Director
|
541
+inf%
8.65
USD 4,680
|
541
+inf%
|
8.65
|
USD 4,680
|
|
2022-08-26 |
2022-08-25 |
B
Purchase
|
Raffin Thomas A.
Non-Executive Director
|
1,150
+13.9%
8.46
USD 9,729
|
1,150
+13.9%
|
8.46
|
USD 9,729
|
|
2022-08-26 |
2022-08-25 |
B
Purchase
|
McCracken Joseph S
Non-Executive Director
|
3,170
+37.1%
8.60
USD 27,262
|
3,170
+37.1%
|
8.60
|
USD 27,262
|
|
2022-08-03 |
2022-08-02 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
3,407
-12.2%
8.11
USD 27,631
|
3,407
-12.2%
|
8.11
|
USD 27,631
|
|
2022-06-07 |
2022-06-06 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
169
-0.6%
7.62
USD 1,288
|
169
-0.6%
|
7.62
|
USD 1,288
|
|
2022-04-05 |
2022-04-05 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
2,214
-7.0%
8.32
USD 18,420
|
2,214
-7.0%
|
8.32
|
USD 18,420
|
|
2021-01-08 |
2021-01-08 |
S
Sale
|
Flynn James E
Large shareholder
|
101,600
-11.5%
22.24
USD 2,259,797
|
101,600
-11.5%
|
22.24
|
USD 2,259,797
|
|
2021-01-08 |
2021-01-08 |
S
Sale
|
Flynn James E
Large shareholder
|
3,912
-0.4%
23.57
USD 92,194
|
3,912
-0.4%
|
23.57
|
USD 92,194
|
|
2021-01-08 |
2021-01-08 |
S
Sale
|
Flynn James E
Large shareholder
|
1,000
-0.1%
24.11
USD 24,108
|
1,000
-0.1%
|
24.11
|
USD 24,108
|
|
2021-01-08 |
2021-01-07 |
S
Sale
|
Flynn James E
Large shareholder
|
4,378
-0.5%
25.05
USD 109,665
|
4,378
-0.5%
|
25.05
|
USD 109,665
|
|
2021-01-08 |
2021-01-07 |
S
Sale
|
Flynn James E
Large shareholder
|
11,794
-1.3%
24.35
USD 287,157
|
11,794
-1.3%
|
24.35
|
USD 287,157
|
|
2021-01-08 |
2021-01-06 |
S
Sale
|
Flynn James E
Large shareholder
|
931
-0.1%
22.64
USD 21,082
|
931
-0.1%
|
22.64
|
USD 21,082
|
|
2021-01-08 |
2021-01-06 |
S
Sale
|
Flynn James E
Large shareholder
|
28,108
-3.0%
22.47
USD 631,620
|
28,108
-3.0%
|
22.47
|
USD 631,620
|
|
2018-07-12 |
2018-07-10 |
S
Sale
|
Talarico Ernest III
Non-Executive Director
|
13,806
-30.0%
4.82
USD 66,600
|
13,806
-30.0%
|
4.82
|
USD 66,600
|
|
2017-11-22 |
2017-11-21 |
PS
Planned sale
|
Langren Carl W.
Principal Accounting Officer
|
2,229
-10.2%
9.05
USD 20,172
|
2,229
-10.2%
|
9.05
|
USD 20,172
|
|
2017-10-06 |
2017-10-06 |
B
Purchase
|
Stine Seed Farm, Inc.
Large shareholder
|
780,487
+11.0%
10.25
USD 7,999,992
|
780,487
+11.0%
|
10.25
|
USD 7,999,992
|
|
2016-12-16 |
2016-12-14 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
3,943
-26.9%
10.85
USD 42,782
|
3,943
-26.9%
|
10.85
|
USD 42,782
|
|
2016-06-08 |
2016-06-06 |
B
Purchase
|
Talarico Ernest III
Non-Executive Director
|
4,065
+14.4%
12.32
USD 50,081
|
4,065
+14.4%
|
12.32
|
USD 50,081
|
|
2016-04-11 |
2016-04-07 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
10,000
-3.4%
20.03
USD 200,250
|
10,000
-3.4%
|
20.03
|
USD 200,250
|
|
2016-03-16 |
2016-03-15 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
5,000
-1.7%
18.60
USD 93,000
|
5,000
-1.7%
|
18.60
|
USD 93,000
|
|
2016-03-16 |
2016-03-15 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
20,000
-6.3%
17.68
USD 353,600
|
20,000
-6.3%
|
17.68
|
USD 353,600
|
|
2016-02-04 |
2016-02-03 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
13,500
-4.1%
24.46
USD 330,210
|
13,500
-4.1%
|
24.46
|
USD 330,210
|
|
2016-02-04 |
2016-02-03 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
11,500
-3.4%
23.81
USD 273,815
|
11,500
-3.4%
|
23.81
|
USD 273,815
|
|
2016-01-06 |
2016-01-06 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
7,900
-2.3%
33.06
USD 261,174
|
7,900
-2.3%
|
33.06
|
USD 261,174
|
|
2016-01-06 |
2016-01-06 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
17,100
-4.6%
32.29
USD 552,159
|
17,100
-4.6%
|
32.29
|
USD 552,159
|
|
2016-01-06 |
2016-01-05 |
S
Sale
|
HENNEMAN JOHN B III
EVP, Chief Financial Officer
Officer
|
175
-0.3%
35.74
USD 6,255
|
175
-0.3%
|
35.74
|
USD 6,255
|
|
2016-01-06 |
2016-01-05 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
500
-3.6%
35.42
USD 17,710
|
500
-3.6%
|
35.42
|
USD 17,710
|
|
2016-01-06 |
2016-01-05 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
595
-4.1%
34.60
USD 20,587
|
595
-4.1%
|
34.60
|
USD 20,587
|
|
2016-01-06 |
2016-01-05 |
S
Sale
|
Vahanian Nicholas N.
President, Chief Medical Offic
Officer
|
1,000
-1.5%
35.57
USD 35,570
|
1,000
-1.5%
|
35.57
|
USD 35,570
|
|
2016-01-06 |
2016-01-05 |
S
Sale
|
Vahanian Nicholas N.
President, Chief Medical Offic
Officer
|
2,011
-2.9%
34.80
USD 69,983
|
2,011
-2.9%
|
34.80
|
USD 69,983
|
|
2016-01-06 |
2016-01-05 |
S
Sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
3,621
-1.0%
35.29
USD 127,785
|
3,621
-1.0%
|
35.29
|
USD 127,785
|
|
2016-01-06 |
2016-01-05 |
S
Sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
1,380
-0.4%
34.46
USD 47,555
|
1,380
-0.4%
|
34.46
|
USD 47,555
|
|
2016-01-06 |
2016-01-05 |
S
Sale
|
Wiley Brian
VP of Business Development
Officer
|
1,000
-4.8%
35.20
USD 35,200
|
1,000
-4.8%
|
35.20
|
USD 35,200
|
|
2016-01-06 |
2016-01-05 |
S
Sale
|
Wiley Brian
VP of Business Development
Officer
|
295
-1.4%
34.26
USD 10,107
|
295
-1.4%
|
34.26
|
USD 10,107
|
|
2015-07-15 |
2015-07-13 |
S
Sale
|
Saluri Joseph
Non-Executive Director
|
5,000
-23.8%
50.42
USD 252,100
|
5,000
-23.8%
|
50.42
|
USD 252,100
|
|
2015-06-03 |
2015-06-01 |
PS
Planned sale
|
Ramsey William J.
Quality Assurance Officer
Officer
|
1,000
-3.0%
42.94
USD 42,940
|
1,000
-3.0%
|
42.94
|
USD 42,940
|
|
2015-06-03 |
2015-06-01 |
PS
Planned sale
|
Ramsey William J.
Quality Assurance Officer
Officer
|
1,500
-4.3%
42.53
USD 63,795
|
1,500
-4.3%
|
42.53
|
USD 63,795
|
|
2015-04-09 |
2015-04-07 |
PS
Planned sale
|
Raffin Thomas A.
Non-Executive Director
|
9,870
-13.6%
55.03
USD 543,146
|
9,870
-13.6%
|
55.03
|
USD 543,146
|
|
2015-04-09 |
2015-04-07 |
PS
Planned sale
|
Raffin Thomas A.
Non-Executive Director
|
10,024
-12.1%
54.32
USD 544,504
|
10,024
-12.1%
|
54.32
|
USD 544,504
|
|
2015-04-09 |
2015-04-07 |
PS
Planned sale
|
Raffin Thomas A.
Non-Executive Director
|
800
-1.0%
53.18
USD 42,544
|
800
-1.0%
|
53.18
|
USD 42,544
|
|
2015-03-20 |
2015-03-18 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
7,000
-12.3%
53.00
USD 371,000
|
7,000
-12.3%
|
53.00
|
USD 371,000
|
|
2015-03-20 |
2015-03-18 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
3,429
-100.0%
53.00
USD 181,737
|
3,429
-100.0%
|
53.00
|
USD 181,737
|
|
2015-03-20 |
2015-03-18 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
3,429
-100.0%
53.00
USD 181,737
|
3,429
-100.0%
|
53.00
|
USD 181,737
|
|
2015-03-20 |
2015-03-18 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
2,500
-100.0%
53.00
USD 132,500
|
2,500
-100.0%
|
53.00
|
USD 132,500
|
|
2015-03-19 |
2015-03-18 |
S
Sale
|
Talarico Ernest III
Non-Executive Director
|
1,000
-3.7%
53.75
USD 53,750
|
1,000
-3.7%
|
53.75
|
USD 53,750
|
|
2015-03-19 |
2015-03-17 |
S
Sale
|
Talarico Ernest III
Non-Executive Director
|
19,532
-42.7%
52.89
USD 1,033,047
|
19,532
-42.7%
|
52.89
|
USD 1,033,047
|
|
2014-10-28 |
2014-10-24 |
S
Sale
|
LINK GORDON H JR
Chief Financial Officer
Officer
|
2,500
-14.8%
40.39
USD 100,975
|
2,500
-14.8%
|
40.39
|
USD 100,975
|
|
2014-02-11 |
2014-02-07 |
S
Sale
|
Saluri Joseph
Non-Executive Director
|
4,761
-29.9%
38.80
USD 184,723
|
4,761
-29.9%
|
38.80
|
USD 184,723
|
|
2014-02-11 |
2014-02-07 |
S
Sale
|
Talarico Ernest III
Non-Executive Director
|
25,000
-48.7%
37.06
USD 926,538
|
25,000
-48.7%
|
37.06
|
USD 926,538
|
|
2014-01-23 |
2014-01-21 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
3,586
-51.1%
34.81
USD 124,833
|
3,586
-51.1%
|
34.81
|
USD 124,833
|
|
2014-01-23 |
2014-01-21 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
3,587
-51.1%
34.81
USD 124,868
|
3,587
-51.1%
|
34.81
|
USD 124,868
|
|
2014-01-17 |
2014-01-15 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
1,414
-16.8%
29.95
USD 42,349
|
1,414
-16.8%
|
29.95
|
USD 42,349
|
|
2014-01-17 |
2014-01-15 |
S
Sale
|
Langren Carl W.
Principal Accounting Officer
Officer
|
1,413
-16.8%
29.95
USD 42,319
|
1,413
-16.8%
|
29.95
|
USD 42,319
|
|
2014-01-09 |
2014-01-07 |
PS
Planned sale
|
LINK GORDON H JR
Chief Financial Officer
Officer
|
453
-3.1%
22.55
USD 10,215
|
453
-3.1%
|
22.55
|
USD 10,215
|
|
2014-01-06 |
2014-01-06 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
9,000
-1.0%
22.44
USD 201,915
|
9,000
-1.0%
|
22.44
|
USD 201,915
|
|
2014-01-07 |
2014-01-03 |
PS
Planned sale
|
Vahanian Nicholas N.
President, Chief Medical Offic
Officer
|
4,196
-4.3%
22.19
USD 93,113
|
4,196
-4.3%
|
22.19
|
USD 93,113
|
|
2014-01-07 |
2014-01-03 |
PS
Planned sale
|
Vahanian Nicholas N.
President, Chief Medical Offic
Officer
|
22,925
-19.7%
22.19
USD 508,724
|
22,925
-19.7%
|
22.19
|
USD 508,724
|
|
2014-01-07 |
2014-01-03 |
PS
Planned sale
|
Vahanian Nicholas N.
President, Chief Medical Offic
Officer
|
41
-0.0%
22.19
USD 910
|
41
-0.0%
|
22.19
|
USD 910
|
|
2014-01-06 |
2014-01-03 |
PS
Planned sale
|
Ramsey William J.
Quality Assurance Officer
Officer
|
8,604
-20.6%
22.00
USD 189,288
|
8,604
-20.6%
|
22.00
|
USD 189,288
|
|
2014-01-06 |
2014-01-03 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
11,000
-1.2%
21.97
USD 241,626
|
11,000
-1.2%
|
21.97
|
USD 241,626
|
|
2013-12-05 |
2013-12-03 |
PS
Planned sale
|
LINK GORDON H JR
Chief Financial Officer
Officer
|
449
-6.5%
20.96
USD 9,410
|
449
-6.5%
|
20.96
|
USD 9,410
|
|
2013-12-02 |
2013-12-02 |
PS
Planned sale
|
Vahanian Nicholas N.
President, Chief Medical Offic
Officer
|
30,000
-30.3%
22.19
USD 665,760
|
30,000
-30.3%
|
22.19
|
USD 665,760
|
|
2013-12-02 |
2013-11-29 |
PS
Planned sale
|
Vahanian Nicholas N.
President, Chief Medical Offic
Officer
|
7,500
-7.0%
22.07
USD 165,556
|
7,500
-7.0%
|
22.07
|
USD 165,556
|
|
2013-11-20 |
2013-11-19 |
PS
Planned sale
|
Link Charles J. Jr.
Chairman of the Board and CEO
Executive Director
|
7,500
-0.9%
18.04
USD 135,269
|
7,500
-0.9%
|
18.04
|
USD 135,269
|
|
2013-11-20 |
2013-11-19 |
PS
Planned sale
|
Vahanian Nicholas N.
President, Chief Medical Offic
Officer
|
3,800
-3.3%
18.04
USD 68,536
|
3,800
-3.3%
|
18.04
|
USD 68,536
|
|